Log In
Print
BCIQ
Print
Print this Print this
 

Soliris, eculizumab

Also known as: formerly 5G1.1

  Manage Alerts
Collapse Summary General Information
Company Alexion Pharmaceuticals Inc.
DescriptionHumanized mAb targeting complement 5 (C5)
Molecular Target Complement 5 (C5)
Mechanism of ActionComplement inhibitor; Antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today